Exclusive speaker interview from MRC Harwell Institute released 4 weeks ahead of SMi’s 3D Cell Culture Conference Read more
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma Read more
GSK: FDA grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma Read more